Robert G. Shawah insider trades

Open-market stock purchases and sales by Robert G. Shawah, Chief Financial Officer at Acurx Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 18, 2014.

Recent trades

DateStockTradeValue
Apr 20, 2026ACXP Acurx Pharmaceuticals, IncBought (not open market)—

Companies traded

  • ACXP Acurx Pharmaceuticals, Inc: other filings, last Apr 20, 2026
  • AMRH AMERI Holdings, Inc: other filings, last Aug 20, 2018
  • DPRX Dipexium Pharmaceuticals, Inc: 1 buy, last Jan 17, 2017

Get free alerts when Robert G. Shawah files a new trade →